title: Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
authors.forename: C U
authors.initials: CU
authors.lastname: Pae
authors.forename: Tae-Suk
authors.initials: TS
authors.lastname: Kim
authors.forename: Jung-Jin
authors.initials: JJ
authors.lastname: Kim
authors.forename: Jeong-Ho
authors.initials: JH
authors.lastname: Chae
authors.forename: Chang-Uk
authors.initials: CU
authors.lastname: Lee
authors.forename: Soo-Jung
authors.initials: SJ
authors.lastname: Lee
authors.forename: In-Ho
authors.initials: IH
authors.lastname: Paik
authors.forename: Chul
authors.initials: C
authors.lastname: Lee
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008875:Middle Aged; D000078785:Mirtazapine; D012148:Restless Legs Syndrome / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine